Mashup Score:5
The LancetPunishing the tortured: criminalisation of suicide - 1 month
Mashup Score:5
Articles from: The Lancet
Mashup Score:6
The LancetOffline: How to fail well in global health - 1 month
Mashup Score:6
I am an expert in how to destroy global health initiatives. It is a peculiar fact that I have been an intimate witness to...
-
Lancet Offline: How to fail well in global health - five uncomfortable facts to keep you alert 💰🌟 https://t.co/tZeWWoo4Er https://t.co/tZeWWoo4Er - view on twitter
Mashup Score:20
The LancetAcute myeloid leukaemia - 1 month
Mashup Score:20
Progress in acute myeloid leukaemia treatment is occurring at an unprecedented pace. The past decade has witnessed an increasingly improved scientific understanding of the...
-
While the number of deaths (80,000 per year) caused by Acute myeloid leukaemia are expected to double, progress in treatment is occurring at an unprecedented pace. A new Seminar summarises current diagnostics, evolving treatments, and emerging research: https://t.co/CvDoZesibx - view on twitter
Mashup Score:10
The LancetAddressing a potential crisis in the Italian National Health System - 1 month
Mashup Score:10
A recent Editorial1 pointed out that the National Health Service (NHS) in the UK is facing its most crucial moment since its inception due...
-
New Correspondence—Addressing a potential crisis in the Italian National Health System: https://t.co/PxYJ4wPohI - view on twitter
Based on a statistically significant, clinically meaningful improvement in overall survival compared with gemcitabine and cisplatin without any new safety signals, pembrolizumab plus gemcitabine...
-
New @TheLancet - Kelley et al - Pembrolizumab plus gemcitabine and cisplatin vs gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966) https://t.co/ZbdRQwzSuW #gitwitter #onctwitter https://t.co/ZbdRQwzSuW - view on twitter
Mashup Score:6
The LancetWorking together across WHO’s regions in an increasingly complex world - 1 month
Mashup Score:6
WHO is unusual within the UN system in having a strong regional structure. Every 5 years all of WHO’s member states meet at the...
-
“There are many health-related issues that transcend WHO's regional borders but do not need to be addressed at the global level.” A Comment from @martinmckee—Working together across WHO's regions in an increasingly complex world: https://t.co/ExCdwzCDMe - view on twitter
Mashup Score:46
The LancetImproving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact - 1 month
Mashup Score:46
The Global Diabetes Compact is a WHO-driven initiative uniting stakeholders around goals of reducing diabetes risk and ensuring that people with diabetes have equitable...
-
Global estimates indicate that 537 million adults have diabetes. In a new Health Policy, Edward W Gregg & colleagues propose and define metrics and targets for the Global Diabetes Compact to stimulate global action: https://t.co/yXPsT0PgiJ https://t.co/yXPsT0PgiJ - view on twitter
Mashup Score:6
The LancetTargeting CLDN18.2 with zolbetuximab significantly prolonged progression-free survival and overall survival when combined with mFOLFOX6 versus placebo plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative,...
-
New @TheLancet - Zolbetuximab + mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT) https://t.co/a56MFLBSCY #gitwitter #onctwitter #gastriccancer https://t.co/a56MFLBSCY - view on twitter
Mashup Score:35
The LancetRitlecitinib was effective and well tolerated in patients aged 12 years and older with alopecia areata. Ritlecitinib might be a suitable treatment option for...
-
Ritlecitinib might be a treatment option for alopecia areata in patients aged 12 years and older, suggests a new study: https://t.co/jKUxEbo4AZ Below, a graphical abstract 👇 https://t.co/jKUxEbo4AZ - view on twitter
Based on a statistically significant, clinically meaningful improvement in overall survival compared with gemcitabine and cisplatin without any new safety signals, pembrolizumab plus gemcitabine...
-
KEYNOTE-966 and TOPAZ-1 are so similar: ⚡️mOS: KN966: 12.7 vs 10.9 mos, HR: 0.83 T1: 12.8 vs 11.5 mos, HR: 0.80 ⚡️ORR: KN966: 29% vs. 28% T1: 27% vs 19% Key Takeaways: 👉 anti-PD-1 is weakly effective in BTCs. 👉 Continue gem in maintenance #AACR2023 https://t.co/4Di4zFWac6 - view on twitter
More coverage:
#aacr2023
Providing care and treatment for people with suicidal ideas, rather than subjecting them to a criminal process, seems intuitively humane and appropriate. And yet,...
The Lancet and @TheLancetPsych have published recent content about the decriminalisation of suicide as a global imperative—read them below. Editorial: https://t.co/a5B4VLBBTl Comment: https://t.co/a5B4VLBBTl - view on twitter